Skip to content

Online PHN CBT for PPD

Online Public Health Nurse-Delivered Group Cognitive Behavioural Therapy for Postpartum Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04928742
Enrollment
159
Registered
2021-06-16
Start date
2020-03-30
Completion date
2022-03-02
Last updated
2022-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Depression

Brief summary

The primary objective of this study is to determine if online group CBT for PPD delivered by public health nurses is superior to postnatal care as usual in: a) acutely treating PPD, b) reducing relapse and recurrence, c) improving common comorbidities and complications of PPD including anxiety and the mother-infant relationship, and d) to determine if this treatment is cost-effective.

Detailed description

A prospective, 1-site, parallel group, RCT (1:1 ratio) in which outcome assessors and data analysts will be blinded to maternal treatment will be used to compare online PHN-delivered group CBT for PPD to postnatal care as usual. The primary objective of this study is to determine if online group CBT for PPD delivered by public health nurses is superior to postnatal care as usual in: a) acutely treating PPD, b) reducing relapse and recurrence, c) improving common comorbidities and complications of PPD including anxiety and the mother-infant relationship, and d) to determine if this treatment is cost-effective. Women in the treatment group will participate in a 9-week group CBT intervention for PPD delivered via Zoom by two public health nurses. It consists of 9 weekly 2-hour sessions where core CBT skills are learned and practiced, and a new psychoeducational topic is introduced and discussed by women each week.

Interventions

The 9-week group CBT intervention for PPD delivered via Zoom by two public health nurses. This intervention was developed by Dr. Van Lieshout (PI) at the Women's Health Concerns Clinic (WHCC) at St. Joseph's Healthcare Hamilton. It was designed to be brief, simple, and applicable to women in community settings. It consists of 9 weekly 2-hour sessions where core CBT skills are learned and practiced, and a new psychoeducational topic is introduced and discussed by women each week.

Sponsors

McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The principal investigator, outcome assessors and data analysts will be blinded to participant allocation.

Intervention model description

Participants will be randomly assigned in a 1:1 ratio to the treatment group (online PHN-delivered group CBT) or the control group (treatment as usual).

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Eligible women will be \>18 years of age, understand and speak English (so that they can participate in the CBT group and complete study measures), have an EPDS score between of 10 or more and meet diagnostic criteria for current major depressive disorder on the Mini International Neuropsychiatric Interview-Plus (MINI-Plus). They will also all be within 12 months of delivering an infant.

Exclusion criteria

* In order to increase the relevance and generalizability of our findings, women can have psychiatric comorbidities with the exception of bipolar disorder, a current psychotic, substance or alcohol use disorder, or antisocial or borderline personality disorder. These are predictors of significant difficulty participating in therapy groups and/or non-response to CBT.

Design outcomes

Primary

MeasureTime frameDescription
Maternal Depressive Symptoms9 weeksEdinburgh Postnatal Depression Scale (EPDS): The EPDS is the 10-item gold standard measure of maternal depressive symptoms. A score \>12 is consistent with PPD and changes in scores of 4 or more points are indicative of clinically significant improvement.

Secondary

MeasureTime frameDescription
Mother-Infant Bonding9 weeksPostpartum Bonding Questionnaire: The Postpartum Bonding Questionnaire is a 25 item maternal report scale that is designed to detect disorders of the mother-infant relationship on four subscales: bonding, rejection and anger, infant-focused anxiety, and incipient abuse.
Social Support9 weeksThe Social Provisions Scale: The SPS is a 24-item self-report measures of the degree to which an individual's social relationships provide support.
Relationship with Partner6 monthsDyadic Adjustment Scale: a 32 item scale that assesses partner relationship on 4 subscales: dyadic consensus, affectional expression, dyadic satisfaction and dyadic cohesion.
Infant Temperament9 weeksInfant Behavior Questionnaire-Revised (very short form): Temperament refers to the ways individuals think, behave, and react and is heavily influenced by the degree to which infants and toddlers can regulate their emotions. Factor analysis of the domains of temperament assessed by the IBQ-R (VSF) indicates that they are consistent with 3 broad dimensions of temperament: emotion regulation, negative affectivity, and extraversion. These subscales have demonstrated good internal consistency and inter-rater reliability between parents. Mothers and fathers will complete the IBQ-R on their infants immediately before treatment, right after treatment, and at 6 months afterward.
Anxiety9 weeksPenn State Worry Questionnaire (PSWQ): The PSWQ is a 16-item self-report scale that taps generalized anxiety disorder, the most common comorbidity of PPD.
Cost Effectiveness - QALY9 weeksCost-effectiveness will be measured using incremental cost per quality-adjusted life year ratio. Quality-Adjusted Life Year (QALY): The EQ-5D-5L is a utility-based health-related quality of life instrument consisting of five questions covering depression/anxiety, usual activities, self-care, pain/ discomfort, and mobility. Its validity in measuring the impact of depression is established. Its Canadian scoring algorithm will be used to convert the five responses to health utility at each measurement occasion.
Maternal Major Depressive Disorder6 monthsMini International Neuropsychiatric Interview (MINI): The MINI is a validated structured diagnostic interview used to assess psychiatric disorders consistent with the DSM-IV. It demonstrates very good agreement with the Structured Clinical Interview for DSM-IV and strong inter-rater reliability has been noted. Major Depressive Disorder Module: Our primary outcome (recurrence) will be assessed at 6 months post-treatment, but in order to compare trajectories of recovery/recurrence/relapse, we will assess these outcomes at baseline, 9 weeks, and 6 months. Relapse will be assessed at 6 months post-CBT completion. Our primary outcome for maternal depression using the MINI will be the proportion of women who meet MINI current MDD diagnostic criteria at 6 months.
Maternal Depressive Symptoms6 monthsEdinburgh Postnatal Depression Scale (EPDS): The EPDS is the 10-item gold standard measure of maternal depressive symptoms. A score \>12 is consistent with PPD and changes in scores of 4 or more points are indicative of clinically significant improvement.
Cost Effectiveness - costs9 weeksCost-effectiveness will be measured using incremental cost per quality-adjusted life year ratio. Costs: Canadian Community Health Survey and the Service Use and Resources Form. We will measure resources consumed over the trial period from the perspective of public health care payer. Corresponding unit costs will be calculated using provincial or other standard billing rates.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 3, 2026